SCHEMBL23964192

SCHEMBL23964192

c1ccc2c(CN3CCN(c4ccncc4)CC3)c[nH]c2c1

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DRD4 P21917 8/20 0.80
▸ DRD2 P14416 7/20 0.80
▸ DRD3 P35462 7/20 0.80
▸ L3MBTL1 Q9Y468 1/20 0.73
▸ BCHE P06276 1/20 0.71
▸ CYP2D6 P10635 1/20 0.71
▸ LMNA P02545 4/20 0.70
▸ HTT P42858 3/20 0.70
▸ POLB P06746 1/20 0.70
▸ TSHR P16473 1/20 0.70
▸ HTR6 P50406 1/20 0.63
▸ KDM4E B2RXH2 1/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ GAA P10253 1/20 0.62
▸ JAK2 O60674 1/20 0.60
▸ RAB9A P51151 1/20 0.60
▸ HTR2A P28223 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.54
▸ TP53 P04637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5198717 0.84 DRD2 (1.00) DRD4DRD2DRD3L3MBTL1BCHE
SCHEMBL14281102 0.84 DRD4 (0.80) DRD4DRD2DRD3L3MBTL1BCHE
SCHEMBL18499093 0.84 L3MBTL1 (1.00) DRD4DRD2DRD3L3MBTL1BCHE
SCHEMBL5198967 0.84 DRD4 (0.80) DRD4DRD2DRD3L3MBTL1BCHE
SCHEMBL5198113 0.84 DRD2 (0.80) DRD4DRD2DRD3L3MBTL1BCHE
SCHEMBL23964231 0.83 DRD4 (0.55) DRD4DRD2DRD3L3MBTL1BCHE
SCHEMBL5196142 0.81 DRD4 (0.74) DRD4DRD2DRD3L3MBTL1BCHE
SCHEMBL946337 0.81 LMNA (0.77) DRD4DRD2DRD3L3MBTL1BCHE
SCHEMBL5196816 0.79 DRD2 (0.71) DRD4DRD2DRD3L3MBTL1BCHE
SCHEMBL10463380 0.78 LMNA (0.97) DRD4DRD2DRD3L3MBTL1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-05-18 — — US disclosed
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2023-05-18 — — US disclosed
CN-115427404-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2022-12-02 — — CN disclosed
WO-2021216665-A9 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2021-12-02 — — WO disclosed
WO-2021216665-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2021-10-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150980-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF COL1A1, COL2A1, COL14A1 DRD4 4746/4885DRD2 4780/4885DRD3 4747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback